Filament Health Corp. (TSE:FH) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Filament Health Corp., a clinical-stage natural psychedelic drug development company, has issued 5.6 million common shares at $0.05 each to entities affiliated with Negev Capital Investments Limited under an advisory agreement for fundraising and strategic advice. The transaction, involving significant shareholders, is deemed a ‘related party transaction,’ but has been approved by the company’s independent directors as fair and reasonable.
For further insights into TSE:FH stock, check out TipRanks’ Stock Analysis page.
